Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Nat Chem Biol. 2020 Jul 21;16(8):817–825. doi: 10.1038/s41589-020-0596-8

Box1 figure:

Box1 figure:

RADD approach for developing inhibitor-target binding models. Schematic shows the RADD approach. Selected candidate compounds are tested against wild-type (WT) and mutant alleles of a chosen target to identify key inhibitor–target interactions that can guide the development of robust binding models.